Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

Withdrawn before enrolling

Conditions studied: Obesity, Prostate Cancer

In brief

The proposed prospective study aims to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. If PSA levels are found to rise after weight loss, interpretation of PSA levels in morbidly obese men may be improved by upward correction of the PSA level. A 'correction factor' may be proposed for the interpretation of PSA levels in obese men, toward the clinical decision regarding indication for prostate biopsy.

Key facts

Study ID

NCT00562341

Run by

Maimonides Medical Center

People needed

0

Starts

2007-11-01

Expected to finish

2009-12-31

Last updated by the study team

2018-08-23

Who can join

Age: 20 and older, up to 60. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• obese men undergoing lap-band surgery

You may not qualify if…

• prior diagnosis of prostate cancer
• prior prostate surgery
• use of 5-alpha reductase inhibitors
• history of prostatitis
• recurrent Urinary Tract Infection (UTI).

Where it is running

• Maimonides Medical Center — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.